Loading clinical trials...
Loading clinical trials...
A Phase IIA Randomised, Double-blind, Double Dummy, Placebo and Active Controlled 5-Way Cross-over Trial to Examine the Bronchodilator Effects of PF-610,355 and to Test for Superiority Versus Placebo in Reversible Asthmatic Patients
Conditions
Interventions
PF-610,355
Salmeterol
Locations
6
Germany
Pfizer Investigational Site
Berlin, Germany
Pfizer Investigational Site
Großhansdorf, Germany
Pfizer Investigational Site
Wiesbaden, Germany
Pfizer Investigational Site
Gothenburg, Sweden
Pfizer Investigational Site
Lund, Sweden
Pfizer Investigational Site
Manchester, United Kingdom
Start Date
May 1, 2007
Last Updated
November 1, 2010
NCT07219173
NCT07486401
NCT02327897
NCT04706988
NCT04639791
NCT06471257
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions